COVID-NMA

Launched in March 2020, COVID-NMA is an international initiative led by the Centre of Research in Epidemiology and StatisticS (METHODS Team) and Cochrane France with key partners the World Health Organization (WHO), Université Paris Cité, Inserm, CNRS, Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark, Odense University Hospital, Epistemonkos Foundation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and University of Milan... The COVID-NMA process is based on three pillars: a living mapping of registered trials, a living systematic review of trial results and a living monitoring of trials transparency... We are searching the WHO International Clinical Trials Registry Platform (ICTRP) once a week to identify and extract data from RCTs evaluating the effectiveness of interventions for preventing and treating COVID-19 as well as of all trials assessing vaccines.

Primary location: Paris France